Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Balloon pulmonary angioplasty (BPA) was first described in 2001 and now has evolved into a class I indication for inoperable or residual chronic thromboembolic pulmonary hypertension. This review article aims to describe evidence from studies performed at various pulmonary hypertension (PH) centers across the globe, to better understand the role of BPA in chronic thromboembolic pulmonary disease with and without PH. Additionally, we hope to highlight innovations and the ever-changing safety and efficacy profile of BPA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccep.2024.12.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots.
Curr Opin Cardiol
August 2025
National Heart and Lung Institute, Imperial College London.
Purpose Of Review: Symptom relief is now recognized as the primary remit of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease. The relationship between the nature of angina symptoms and the likelihood of successful symptom relief from PCI had not been systematically studied until recently.
Recent Findings: The ORBITA-2 symptom-stratified analysis found that while the severity and nature of symptoms were poorly associated with the severity of coronary disease, the nature of the symptoms powerfully predicted the efficacy of PCI in relieving angina.
Robot-assisted percutaneous coronary intervention: a prospective, multicenter, randomized controlled, non-inferiority clinical trial.
J Geriatr Cardiol
August 2025
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing,
Objective: To evaluate the safety and effectiveness of robot-assisted percutaneous coronary intervention (R-PCI) compared to traditional manual percutaneous coronary intervention (M-PCI).
Methods: This prospective, multicenter, randomized controlled, non-inferior clinical trial enrolled patients with coronary heart disease who met the inclusion criteria and had indications for elective percutaneous coronary intervention. Participants were randomly assigned to either the R-PCI group or the M-PCI group.
Removal of a Central Venous Catheter Impacted in the Peripheral Pulmonary Artery Using a Balloon Catheter.
Interv Radiol (Higashimatsuyama)
August 2025
Department of Radiology, Mie University Hospital, Japan.
Disruption of the central venous port catheter was identified on the chest radiograph of a 36-year-old woman who had undergone chemotherapy following resection of her colon cancer. Computed tomography revealed that the catheter was impacted in the peripheral pulmonary artery. Instead of using a snare wire, a balloon catheter was inserted into the lumen of the disrupted catheter due to its tight lodging in the pulmonary artery.
View Article and Find Full Text PDFTherapeutic treatment of lung nodules by ablation is a new field. Even though not considered standard of care, lung nodule ablation can be appropriate for select cases. Even though ablation is a safe and well-tolerated procedure, bleeding is a potential complication.
View Article and Find Full Text PDFDifferences between 2 cryoballoon systems in achieving successful pulmonary vein isolation in patients with challenging anatomies.
Heart Rhythm O2
August 2025
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Background: A new technology, the POLAR cryoballoon system, was designed to enhance maneuvering and stabilizing catheter positions with a softer balloon and more deflectable sheath. These novel characteristics may help achieve successful pulmonary vein (PV) isolation in difficult cases when conventional balloons were used.
Objective: This study aimed to investigate the differences in the lesion profiles, touch-up radiofrequency ablation (RFA) rate, and anatomical predictors of acute PV isolation between the POLAR and Arctic Front Advance Pro (AFA-Pro).